Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 10-Jan-23 5:14 PM View:  | Ra Capital Management, LLC Director 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 06-Jan-23 | Private Purchase | 1,853,000 | $2.21 | $4,095,130.00 | 43% 4.29M to 6.14M | |
| 14-Jan-22 5:58 PM View: | Seidel-Dugan Cynthia Chief Scientific Officer | Werewolf Therapeutics, Inc. (HOWL) | 12-Jan-22 | Option Exercise | 39,731 | $2.81 | $111,838.00 | 32% 125.16K to 164.89K | |
| 04-Jan-22 4:26 PM View: | Leonard Reid Chief Operating Officer | Werewolf Therapeutics, Inc. (HOWL) | 30-Dec-21 | Option Exercise | 14,102 | $1.56 | $21,999.10 | 12% 122.16K to 136.26K | |
| 17-Dec-21 4:17 PM View: | Leonard Reid Chief Operating Officer | Werewolf Therapeutics, Inc. (HOWL) | 15-Dec-21 | Market Sale (Planned) | 3,000 | $13.41 | $40,241.60 | (2%) 125.16K to 122.16K | < 1% |
| 16-Jun-21 4:58 PM View: | Ra Capital Management, LLC Director 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 16-Jun-21 | Market Purchase | 9,285 | $13.37 | $124,140.00 | < 1% 12.84M to 12.85M | (4%) |
| 16-Jun-21 4:58 PM View: | Ra Capital Management, LLC Director 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 15-Jun-21 | Market Purchase | 7,958 | $12.95 | $103,056.00 | < 1% 12.83M to 12.84M | (< 1%) |
| 16-Jun-21 4:58 PM View: | Ra Capital Management, LLC Director 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 14-Jun-21 | Market Purchase | 306,055 | $12.75 | $3,902,200.00 | 2% 12.53M to 12.83M | < 1% |
| 06-May-21 4:19 PM View: | Evnin Luke Director 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Market Purchase | 150,799 | $16.00 | $2,412,780.00 | 1% 11.48M to 11.63M | |
| 06-May-21 4:20 PM View: | Mpm Bioventures 2014, L.P. 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion | 3,062,240 | -- | -- | 57% 5.36M to 8.42M | |
| 04-May-21 4:31 PM View: | Asanuma Sakae Director 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion Duplicate | 1,756,410 | -- | -- | 100% 0 to 1.76M | |
| 04-May-21 4:30 PM View: | Longwood Fund III Gp, LLC 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion | 1,427,080 | -- | -- | 100% 0 to 1.43M | |
| 04-May-21 4:30 PM View: | Lazarus Alon Director 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Market Purchase Duplicate | 400,000 | $16.00 | $6,400,000.00 | 24% 1.65M to 2.05M | |
| 04-May-21 4:31 PM View: | Taiho Ventures LLC 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Market Purchase | 312,500 | $16.00 | $5,000,000.00 | 18% 1.76M to 2.07M | |
| 06-May-21 4:31 PM View: | Ra Capital Management, LLC Director 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Market Purchase | 1,715,000 | $16.00 | $27,440,000.00 | 76% 2.25M to 3.97M | |
| 04-May-21 1:21 PM View: | Sphera Global Healthcare Ma... 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion | 312,997 | -- | -- | 100% 0 to 313.0K | |
| 04-May-21 12:34 PM View: | Flynn James E 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Market Purchase | 800,000 | $16.00 | $12,800,000.00 | 46% 1.75M to 2.55M | |
| 06-May-21 4:19 PM View: | Gadicke Ansbert 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion | 5,965,780 | -- | -- | 50% 11.83M to 17.79M | |
| 06-May-21 4:20 PM View: | Mpm Bioventures 2014, L.P. 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Market Purchase | 125,759 | $16.00 | $2,012,140.00 | 1% 8.42M to 8.55M | |
| 04-May-21 4:31 PM View: | Asanuma Sakae Director 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Market Purchase Duplicate | 312,500 | $16.00 | $5,000,000.00 | 18% 1.76M to 2.07M | |
| 04-May-21 4:30 PM View: | Longwood Fund III Gp, LLC 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Market Purchase | 250,000 | $16.00 | $4,000,000.00 | 18% 1.43M to 1.68M | |
| 04-May-21 4:31 PM View: | Arkin Bio Ventures 2 L.P. 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion Duplicate | 1,646,630 | -- | -- | 100% 0 to 1.65M | |
| 04-May-21 1:21 PM View: | Sphera Global Healthcare Ma... 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Market Purchase | 475,000 | $16.00 | $7,600,000.00 | 152% 313.0K to 788.0K | |
| 06-May-21 4:19 PM View: | Evnin Luke Director 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion | 3,671,960 | -- | -- | 47% 7.81M to 11.48M | |
| 06-May-21 4:19 PM View: | Gadicke Ansbert 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Market Purchase | 245,000 | $16.00 | $3,920,000.00 | 1% 17.79M to 18.04M | |
| 04-May-21 4:30 PM View: | Upmc 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion | 1,097,760 | -- | -- | 100% 0 to 1.1M | |
| 04-May-21 4:30 PM View: | Lazarus Alon Director 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion | 1,646,630 | -- | -- | 100% 0 to 1.65M | |
| 04-May-21 4:31 PM View: | Arkin Bio Ventures 2 L.P. 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Market Purchase | 400,000 | $16.00 | $6,400,000.00 | 24% 1.65M to 2.05M | |
| 04-May-21 4:31 PM View: | Taiho Ventures LLC 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion | 1,756,410 | -- | -- | 100% 0 to 1.76M | |
| 06-May-21 4:31 PM View: | Ra Capital Management, LLC Director 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion | 2,253,580 | -- | -- | 100% 0 to 2.25M | |
| 05-May-21 4:00 PM View: | Hbm Bioventures Cayman Ltd 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion | 625,995 | -- | -- | 100% 0 to 626.0K | |
| 04-May-21 12:34 PM View: | Flynn James E 10% Owner | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion | 1,752,790 | -- | -- | 100% 0 to 1.75M |
